ESC Clinical Practice Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes:
KEYWORDS: diabetes, cardiovascular, disease, heart, type, type diabetes, risk, failure, atherosclerotic, kidney, cardiovascular disease, heart failure, kidney disease, chronic, inhibitor

knowledge gap since patients with type 1 diabetes need to know if these medications can help them too. Central Illustration Cardiovascular disease Type 2 diabetes mellitus Presentation Pancreas The disease the Heart Artery patient has already Type 2 diabetes Cardiovascular disease Chronic kidney disease Evaluation Confirmed Confirmed Confirmed The diseases the doctor checks for Cardiovascular disease and type 2 diabetes Type 2 diabetes Diagnosis Type 2 diabetes and Type 2 diabetes and and atherosclerotic The confirmed heart failure chronic kidney disease cardiovascular disease diseases SGLT2 SGLT2 GLP-1 RA SGLT2 inhibitor Finerenone inhibitor inhibitor Treatment The medication the patient All medications are added to existing treatments and are not related to glucose control should receive Therapeutic Lifestyle Modification The ESC Guidelines recommend lifestyle changes as another type of therapy to reduce cardiovascular risk in patients with diabetes including: • Weight control – reduction in weight is recommended when necessary • Increasing physical activity and exercise – any increase in steps per day will help your physical and mental wellbeing • Smoking cessation – stopping smoking is a key way to reduce cardiovascular risk in all people • Controlling cardiovascular risk factors – lowering high levels of blood pressure and cholesterol is
